Prognostically, increased HO-1 has been linked to improved survival in colorectal, gastric, small-intestinal adenocarcinoma, and oral squamous carcinoma, and subcellular distribution appears relevant based on data from head and neck, breast, and colorectal cancers [30,31]. Here, HMOX1 is linked to small intestine adenocarcinoma.